Open access · CC-BY
via OpenAlex
Natural small molecules regulating the mitophagy pathway counteract the pathogenesis of diabetes and chronic complications
Ye Du, Junping Zhu, Shengrui Su, Yunfeng Yu, Jun Zhang, Yuman Yin, Chuanquan Lin, Xue‐Jiao Xie, Xiang Qin, Rong Yu
Frontiers in Pharmacology · 2025 · ▲ 17 citations
Mitochondrial dysfunction
Altered intercellular communication
Chronic inflammation
Disabled macroautophagy
Human
Review
Abstract
Diabetes mellitus (DM) is a chronic metabolic disorder marked by sustained hyperglycemia. These disturbances contribute to extensive damage across various tissues and organs, giving rise to severe complications such as vision loss, kidney failure, amputations, and higher morbidity and mortality rates. Furthermore, DM imposes a substantial economic and emotional burden on patients, families, and healthcare systems. Mitophagy, a selective process that targets the clearance of damaged or dysfunctional mitochondria, is pivotal for sustaining cellular homeostasis through mitochondrial turnover and recycling. Emerging evidence indicates that dysfunctional mitophagy acts as a key pathogenic driver in the pathogenesis of DM and its associated complications. Natural small molecules are particularly attractive in this regard, offering advantages such as low toxicity, favorable pharmacokinetic profiles, excellent biocompatibility, and a broad range of biochemical activities. This review systematically evaluates the mechanistic roles of natural small molecules-including ginsenosides, resveratrol, and berberine-in enhancing mitophagy and restoring mitochondrial homeostasis via activation of core signaling pathways (e.g., PINK1/Parkin, BNIP3/NIX, and FUNDC1). These pathways collectively ameliorate pathological hallmarks of DM, such as oxidative stress, chronic inflammation, and insulin resistance. Furthermore, the integration of nanotechnology with these compounds optimizes their bioavailability and tissue-specific targeting, thereby establishing a transformative therapeutic platform for DM management. Current evidence demonstrates that mitophagy modulation by natural small molecules not only offers novel therapeutic strategies for DM and its chronic complications but also advances the mechanistic foundation for future drug development targeting metabolic disorders.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fphar.2025.1571767
- Canonical
- link ↗
- Fetched
- 2026-09-06 MST
Cite this
APA
Du, Y., Zhu, J., Su, S., Yu, Y., Zhang, J., Yin, Y., Lin, C., Xie, X., Qin, X., & Yu, R. (2025). Natural small molecules regulating the mitophagy pathway counteract the pathogenesis of diabetes and chronic complications. <em>Frontiers in Pharmacology</em>. https://doi.org/10.3389/fphar.2025.1571767
Vancouver
Du Y, Zhu J, Su S, Yu Y, Zhang J, Yin Y, et al. Natural small molecules regulating the mitophagy pathway counteract the pathogenesis of diabetes and chronic complications. Frontiers in Pharmacology. 2025. doi:10.3389/fphar.2025.1571767.
BibTeX
@article{ye2025Natura,
title = {Natural small molecules regulating the mitophagy pathway counteract the pathogenesis of diabetes and chronic complications},
author = {Ye Du and Junping Zhu and Shengrui Su and Yunfeng Yu and Jun Zhang and Yuman Yin and Chuanquan Lin and Xue‐Jiao Xie and Xiang Qin and Rong Yu},
journal = {Frontiers in Pharmacology},
year = {2025},
doi = {10.3389/fphar.2025.1571767},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
npj Aging 2026
Open access · CC-BY
Targeting mitophagy for neuroprotection: mechanisms and therapeutic opportunities
Cells 2025
Open access · CC-BY
Mitochondrial Dysfunction: The Silent Catalyst of Kidney Disease Progression
Frontiers in Neurology 2025
Open access · CC-BY
Receptor-mediated mitophagy: a new target of neurodegenerative diseases
Antioxidants 2023
Open access · CC-BY
Herbal/Natural Compounds Resist Hallmarks of Brain Aging: From Molecular Mechanisms to Therapeutic Strategies
Biomedicine & Pharmacotherapy 2022
Open access · CC-BY
Are mitophagy enhancers therapeutic targets for Alzheimer’s disease?
International Journal of Environmental Sciences 2025
Open access · CC-BY